Floatz logo

Nabiximols

Advanced Cancer

Jazz PharmaceuticalsmixturePhase 3Dormant
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
71/ 100
Competitive Position
73/ 100

Competitive context

1412 Active assets in the Advanced Cancer cohort.

Asset / SponsorPhaseRating
Inno-206
M.D. Anderson Cancer Center
Phase 2BB
Vitamin B6
M.D. Anderson Cancer Center
Phase 4BB
Rivoceranib
Jiangsu HengRui Medicine Co., Ltd.
Phase 4BB
Desflurane
Peter MacCallum Cancer Centre, Australia
Phase 4BB
PROPOFOL
Hong Kong Children's Hospital
Phase 4BB

View all 50 →

Same molecule, other indications

Nabiximols is also rated in:

SpasticityDormant
BBB
Indicative ·
78 / 100
View asset →
PainDormant
BBB
Indicative ·
74 / 100
View asset →
peripheral neuropathyDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →